SCHEMBL27656366

SCHEMBL27656366

CCc1cccc(C(=O)NN)c1C

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.50
CTSD P07339 2/20 0.47
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
CLCN2 P51788 1/20 0.42
ALDH1A1 P00352 4/20 0.42
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
HTT P42858 1/20 0.42
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
GAA P10253 1/20 0.41
KDM4E B2RXH2 3/20 0.41
NLRP3 Q96P20 1/20 0.41
HSD17B10 Q99714 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
F2R P25116 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9877291 0.83 P2RX7 (0.45) P2RX7CTSDCA1CA2CA9
SCHEMBL3135538 0.82 CTSD (0.56) P2RX7CTSDCA1CA2CA9
SCHEMBL14761398 0.81 CTSD (0.47) P2RX7CTSDCA1CA2CA9
SCHEMBL1334610 0.81 PARP1 (0.47) CLCN2ALDH1A1GABRA1GABRB2MAPT
SCHEMBL1892417 0.81 GABRA1 (0.45) CLCN2ALDH1A1GABRA1GABRB2HTT
SCHEMBL668153 0.81 P2RX7 (0.53) P2RX7CTSDCA1CA2CA9
SCHEMBL28708772 0.80 GABRA1 (0.48) CLCN2ALDH1A1GABRA1GABRB2HTT
SCHEMBL27807211 0.80 TAS1R3 (0.47) P2RX7CTSDCA1CA2CA9
SCHEMBL28244196 0.80 HPGD (0.60) ALDH1A1HTTHPGDKDM4EHSD17B10
SCHEMBL2467646 0.79 P2RX7 (0.56) P2RX7CTSDCA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1964622-B Mutant receptors and their use in nuclear receptor-based inducible gene expression systems INTREXON CORP. (US) 2015-08-26 CN disclosed
CN-1964622-A Mutant receptors and their use in nuclear receptor-based inducible gene expression systems RHEOGENE INC (US) 2007-05-16 CN disclosed